Nanobiotix Names New CEO to Develop NBTXR3 for Liver Cancer, Other Diseases
Nanobiotix has named veteran pharmaceutical executive Alain Dostie as its chief operating officer. Among other functions, Dostie will lead the development, manufacturing, market access and…